SUMICHEM · Sumitomo Chemical India Ltd · Chemical Manufacturing
SUMICHEM · Sumitomo Chemical India Ltd · Chemical Manufacturing
As of 05 Nov close
52-week range
42.7% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹1,063 Cr
Revenue YoY
PAT YoY
+20.5%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
6.8
P/S (TTM)
7.3
Sector P/E
20.6
Dividend yield
+0.3%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| SUMICHEM (this stock) | 36.3 | 6.8 | +17.9% | +17.1% | 0.02 | +0.3% |
| Asian Paints | 53 | 11.1 | +12.8% | +22.3% | 0.18 | +1.1% |
| Solar Industries India | 99.6 | 26.6 | +17.6% | +31.4% | 13.68 | +0.1% |
| Pidilite Industries | 61.3 | 19.4 | +17.2% | +24.4% | 0.04 | +0.7% |
Promoter
stable
FII
falling 1q
MF
7.27% (+0.39pp)
rising 2q
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
- lowbusiness-standard.com· 26 Oct 2026, 10:16 amQ2 results: Paytm, REC, Tata Consumer Products among 98 firms on October 26
Concalls & investor presentations
AI-generatedKey takeaway: Sumitomo Chemical India Limited (SUMICHEM) reported Q2 and H1 FY27 results, highlighting challenges from erratic monsoons and lower agrochemical consumption. Revenue for Q2 was INR907 crores, down 2% YoY, while H1 revenue was INR1,971 crores, down 1% YoY. Despite industry volume declines, SCIL maintained stable revenue and EBITDA margins near historical levels. Domestic sales grew 2% in Q2, while exports fell 23% due to inventory liquidation. Key products like Flumioxazin and Topgrain saw growth, with Topgrain being the first global launch of a patented biostimulant. The company emphasized its 'Good to Great' transformation, focusing on operational efficiency, technology, and cross-functional collaboration. Capex projects at Dahej and Tarapur aim to expand domestic production, with commercialization expected by FY28. Management noted uncertainties around semiconductor opportunities and discussed potential glyphosate market gains due to regulatory changes. The balance sheet remained strong with INR2,523 crores in cash, and inventory management efforts were underway to normalize levels. Strategic discussions on new product launches and diversification were ongoing, with a focus on agrochemicals and related sectors.
The summary reflects the company's factual reporting on performance, challenges, and strategic initiatives without overtly positive or negative language.
Sourced from an exchange-filed transcript, dated 30 Oct 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation by Sumitomo Chemical India Limited for the quarter ended June 30, 2026, reported a modest revenue increase of 1% year-on-year to Rs. 1,063 crore, despite challenges in the Indian agrochemical sector due to adverse weather conditions. Management highlighted a 4% growth in gross profit, with the gross margin improving to 39.2%. Operating EBITDA rose by 6% to Rs. 233 crore, and the EBITDA margin expanded to 21.9%. The company recognized an exceptional insurance claim of Rs. 27 crore related to a previous fire incident, leading to a 20% increase in net profit to Rs. 215 crore. The presentation also noted a strong export performance, contributing 16% to revenues, and outlined ongoing initiatives for product launches and enhanced commercial execution. Additionally, the company announced changes in its board of directors effective September 1, 2026.
The presentation conveyed both resilience in financial performance and challenges faced in the operating environment.
Sourced from an exchange-filed presentation, dated 27 Jul 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The earnings call for Sumitomo Chemical India Limited, held on May 28, 2026, discussed the company's financial performance for the fiscal year ending March 31, 2026. Management reported that the agrochemical industry faced significant challenges, including adverse weather and geopolitical tensions, yet the company achieved record profitability with a PAT of INR 543 crores, a 7% year-on-year increase. The gross profit margin was reported at 42%, and EBITDA margin at 20.7%. Management highlighted a 3% growth in revenue, driven by a strong performance in herbicides and a resilient domestic market. They also announced changes in leadership, with Dr. Suresh Ramachandran set to become the new Managing Director in September 2026. The company plans to continue investing in new product launches and expanding its manufacturing capabilities. Management expressed cautious optimism for FY '27, closely monitoring monsoon conditions and cost pressures from raw materials.
Management reported strong financial results while acknowledging significant challenges in the operating environment.
Sourced from an exchange-filed transcript, dated 04 Jun 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Sumitomo Chemical India Limited (SCIL) reported its financial results for the quarter and year ended March 31, 2026, highlighting a stable performance despite challenges in the agrochemical industry. Revenue for Q4FY26 was Rs. 684 crore, a 1% increase year-on-year, while FY26 revenue grew 3% to Rs. 3,238 crore. The company achieved its highest profitability, with a 12% increase in PAT for Q4FY26 and a 7% increase for FY26. Management noted that domestic business grew 4% year-on-year, while export revenues faced a decline due to softer demand. SCIL emphasized disciplined pricing and a favorable product mix as key factors in maintaining profitability. The presentation also outlined future strategies focusing on demand generation, product offerings, and operational agility. Additionally, the company announced changes in its board of directors effective September 1, 2026, and highlighted its commitment to innovation and sustainability.
The document presented a balanced view of the company's performance and future strategies without strong positive or negative emphasis.
Sourced from an exchange-filed presentation, dated 27 May 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedSumitomo Chemical India Limited reported a decline in both domestic sales and exports in FY2023-24, with domestic sales decreasing to ₹22,509.79 million and exports dropping to ₹5,553.02 million. The company faces challenges including dependence on Chinese raw materials, climate change impacts, and competition from counterfeit pesticides. It has robust internal controls and no material audit issues, but has several pending tax disputes and contingent liabilities. The company is focusing on new product launches and capacity expansion.
- Domestic sales decreased from ₹26,068.92 million in 2022-23 to ₹22,509.79 million in 2023-24.
- Exports declined from ₹8,663.65 million in 2022-23 to ₹5,553.02 million in 2023-24.
- The company has pending tax disputes and contingent liabilities related to income tax, service tax, customs duty, and VAT/sales tax.
- Sumitomo Chemical India Limited has robust internal controls and no material audit issues.
- The company is planning new product launches and capacity expansion, leveraging its parent company's portfolio.
Key takeaway: Sumitomo Chemical India Limited faces sales declines and operational challenges, including supply chain dependencies and tax disputes, but maintains strong internal controls and is investing in growth through new products and capacity expansion.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
No item of a kind that needs attention was stored for this company.
Contingent Liability
2 occurrencesRecent (last 12 months)
The company has pending litigations and proceedings related to tax matters (income tax, service tax, customs duty, VAT/sales tax, goods and service tax) and consumer claims, which are classified as contingent liabilities. The company has made provisions where required and disclosed these liabilities in its financial statements.
Earlier (1-3 years ago)
The company has contingent liabilities related to tax matters, including demands raised by authorities against which the company has filed an appeal, and claims by consumers not acknowledged as debts.
Related-Party Transaction
2 occurrencesRecent (last 12 months)
The company approved transactions with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2026-27, with an aggregate value of ₹16,235 million.
Earlier (1-3 years ago)
The company is seeking approval for material related party transactions with Sumitomo Chemical Company, Limited during the Financial Year 2024-25.
Statutory dues in dispute
2 occurrencesRecent (last 12 months)
The company has pending disputes with various authorities including the Superintendent of Central Excise, Mumbai, and Commissioner of Customs, Import (Appeal), related to service tax, excise duty, and custom duty for different periods, with amounts ranging from 0.07 to 1.50 million.
Earlier (1-3 years ago)
The company has outstanding statutory dues for income-tax, sales-tax, service tax, duty of custom, and value added tax, with amounts ranging from 0.14 to 66.45 million INR, pending in various forums including the Mumbai High Court, ITAT, and various commissioners.